• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 7, Issue 11
  3. Author

Online ISSN: 2515-8260

Volume7, Issue11

Comparative Assessment Of Efficacy Of Four Different Topical Drugs In The Management Of Tinea Corporis And Tinea Cruris

    Dr. Neeraj Kumar Dr. Neeraj Kumar

European Journal of Molecular & Clinical Medicine, 2020, Volume 7, Issue 11, Pages 4765-4769

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Aim: comparative assessment of efficacy of topical amorolfine, luliconazole, sertaconazole, terbinafine in tinea corporis and tinea cruris.
Material and methods: This was a prospective, randomized study was done in the  Department of  skin and VD, Vardhman Institute of Medical Sciences, Pawapuri, Nalanda, Bihar, India for one year Total 100 divided into four groups with 25 patients in each category of antifungal were considered. Consecutive eligible patients were prescribed topical amorolfine (0.25%), luliconazole (1%), sertaconazole (2%) and terbinafine (1%) in a serial order. We evaluated the improvement in the pruritus, erythema and scaling with score 0 for no improvement, score 1 for partial improvement and score 2 for complete improvement. Therapeutic response was statistically evaluated using Kruskal Wallis test and Fishers exact test.
Results: Among 100 patients 44 were treatment naive, 25 were topical steroid (with or without antifungal) modified cases, 23 were partially treated with antifungals and 8 had used home remedies prior to the study. Luliconazole showed best improvement of pruritus (mean-1.53), erythema (mean-1.48) and scaling (mean- 1.47). Terbinafine showed the least improvement with mean being 0.62, 0.52, 0.77 for pruritis, erythema and scaling respectively. Difference in the mean values of improvement of luliconazole as compared to the other three drugs was significant for pruritus (P=0.019) and highly significant for erythema and scaling (P=0.003&0.006). A total of 16 patients (64%) in luliconazole group showed good response as compared to the other drugs. These differences in the improvement of patients was statistically significant as compared to other drugs (P= 0.014).
Conclusion: We concluded that the Luliconazole is better as compared to other antifungal. 
Keywords:
  • PDF (178 K)
  • XML
(2021). Comparative Assessment Of Efficacy Of Four Different Topical Drugs In The Management Of Tinea Corporis And Tinea Cruris. European Journal of Molecular & Clinical Medicine, 7(11), 4765-4769.
Dr. Neeraj Kumar Dr. Neeraj Kumar. "Comparative Assessment Of Efficacy Of Four Different Topical Drugs In The Management Of Tinea Corporis And Tinea Cruris". European Journal of Molecular & Clinical Medicine, 7, 11, 2021, 4765-4769.
(2021). 'Comparative Assessment Of Efficacy Of Four Different Topical Drugs In The Management Of Tinea Corporis And Tinea Cruris', European Journal of Molecular & Clinical Medicine, 7(11), pp. 4765-4769.
Comparative Assessment Of Efficacy Of Four Different Topical Drugs In The Management Of Tinea Corporis And Tinea Cruris. European Journal of Molecular & Clinical Medicine, 2021; 7(11): 4765-4769.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 331
  • PDF Download: 772
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus